Elevation Oncology Announces $65M Series B Financing and Promotion of Founder Shawn M. Leland to Chief Executive Officer

$65M Series B Raise Led by New Investors venBio Partners and Cormorant Asset Management, with Participation by Boxer Capital of Tavistock Group, Janus Henderson, Samsara Biocapital, Vivo Capital, and All Existing Series A Investors Shawn M. Leland, Foun... Biopharmaceuticals, Oncology, Venture Capital, Personnel Elevation Oncology, seribantumab
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news